Reuters logo
4 months ago
BRIEF-AFT Pharmaceuticals receives commercialisation licence for novatears in australia and new zealand
March 20, 2017 / 7:59 PM / 4 months ago

BRIEF-AFT Pharmaceuticals receives commercialisation licence for novatears in australia and new zealand

1 Min Read

March 21 (Reuters) - AFT Pharmaceuticals Ltd:

* AFT in-licenses novatears® in australia and new zealand

* Novaliq has granted aft an exclusive license for commercialisation of novatears across australasia

Source text for Eikon:

Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below